Data-Driven Insights

May 21, 2015   |   Sunay Shah

Channel Collaboration Series: Making Pharma Trade Agreement Management Collaborative

Manufacturers and their trade partners work closely to define the parameters and metrics they will measure to ensure maximum value is extracted from the channel when they structure their pay-for-performance contracts. The metrics that are selected and how they are measured vary greatly between manufacturers as there is little evidence of what metrics drive value extraction from the channel.

Read More

Tags: , ,

May 20, 2015   |   Kevin Leininger

Insights from CBI’s Customized Distribution and Pharmacy Strategies Summit

I gave an interesting presentation to a group of pharmacy distribution experts at the recent CBI Customized distribution and Pharmacy Strategies Summit and would like to share some of my insights from the conference. The retail channel is undergoing a significant change and must be thought of and managed differently than in the past. The retail channel is saturated with product and it is getting harder and harder to get product on shelves. It is getting harder and harder to have the right amount of product available for purchase: too little and you risk therapeutic interchange and too much and […]

Read More

Tags: , ,

May 14, 2015   |   Tisha Agarwal

Reality Check for Product Launch: How IntegriChain Can Add Value

There is significant work to be done pre-launch: from defining the market, creating a vision for the brand, identifying leverage points, prioritizing stakeholders, and segmenting the market to creating a value proposition for the brand, creating positioning, messaging, and a go-to-market model, and identifying metrics that will track whether the launch was successful. There is tremendous pressure to get it right and maximize the launch.

Read More

Tags: ,

April 8, 2015   |   Dave Weiss

Best Practices for Next-Generation Distribution Contract Automation

Whether you are a small, medium, or large company, the amount you invest in the channel is significant. Regardless of your size, however, there are ways to equalize the distribution battlefield. A key is to get access to your channel data and put it to use to drive business value.

Read More

April 6, 2015   |   Josh Halpern

We’re Back! The IntegriChain Blog Is Relaunched and New Website Is All Systems Go

The IntegriChain blog is back and alive and well. With the launch of our new website, we are relaunching our blog as well with the promise to continue to provide regular data-driven insights for building the healthcare channel.

Check back in the next couple of days as we dive deeper into best practices for next-generation distribution contract automation by subject-matter expert Dave Weiss, and as we announce the keynote of the IntegriChain User Conference scheduled for this fall.

Read More

June 3, 2014   |   Ally Hanlon

Dr. Adam Fein to Keynote IntegriChain’s 6th Annual Innovation Summit

Adam J. Fein, Ph.D. to Keynote at Innovation Summit

The IntegriChain team is very excited to announce that Adam J. Fein, Ph.D., will be the keynote at this year's IntegriChain Innovation Summit, being held September 8th - September 10th at the Omni William Penn Hotel in Pittsburgh, PA!

As the keynote speaker, Dr. Fein will be the cherry on top of our content-rich agenda. Dr. Fein is the President of Pembroke Consulting and CEO of Drug Channels Institute and is one of the country's foremost experts on pharmaceutical economics and the drug distribution system. Top manufacturers call on Dr. Fein's insights and judgement to create successful commercial strategies and make better strategic decisions in the evolving healthcare environment. Dr. Fein excels at unlocking and explaining complex business and economics issues with humor and an accessible, straightforward style, and has thus become a popular and authoritative figure in the industry.

Read More


April 29, 2014   |   Jason Bogroff

Guest Blog Post: Jason Bogroff of Blue Fin Group on Specialty Data

Jason Bogroff Blue Fin Group

The IntegriChain team will be attending the Armada Specialty Pharmacy Summit & Expo next week in Las Vegas, NV. With specialty pharmacy at the forefront of our minds, we have asked Jason Bogroff, Principal Consultant at Blue Fin Group, to share with us his insights into specialty pharmacy, including emerging pharmacy models and implications of specialty data.

Jason is a sought after expert in translating technical complexity and ambiguity into innovative tactics and executable plans. He is recognized for his creative excellence in applying his combination of business and technical acumen to client needs that span the breadth of Healthcare commerce. Blue Fin Group clients have mined significant value as Jason applies his outstanding project management skills and deep methodology understanding across the areas of channel and customer operations, forecasting, planning and replenishment, channel data and analytics, enterprise technology, logistics and engineering, product and service design and development, and business process design and optimization.

Read More


adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand